Peter Donato has sold STIM and made no open-market buys since Mar 2019
VP and CFO at Neuronetics, Inc.
SEC CIK 0001408320 · Filings on SEC.gov ↗
Every filing
3 filings since Mar 2019, newest first
About Peter Donato
Peter Donato is a person and a seasoned life-sciences finance executive who served as Vice President and Chief Financial Officer of Neuronetics, Inc. (NASDAQ: STIM), a role tied to the company’s commercial-stage neurotechnology business.( He is widely cited for helping lead Neuronetics’ successful IPO in 2018 and for holding senior finance roles across medical device and health-care companies, including Assurex Health, Bovie Medical (now Apyx Medical), Cyberonics (now LivaNova), and Iris International.(
After Neuronetics, Donato continued in CFO leadership roles at companies such as Zomedica, Impulse Dynamics, and Standard Bariatrics, where he helped guide a later sale to Teleflex.( His background spans nearly 30+ years in finance and executive leadership, primarily in the life sciences sector, and he holds a magna cum laude degree from The Ohio State University’s Fisher College of Business and an MBA from the University of Akron.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.